1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. GSK PLC - ADR
50.22 -0.40 (-0.79%)
4.4M
XNYS Volume

XNYS 08 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert

Analyst Downgrade
Barclays downgrades GSK to an 'Underweight' rating; cites lack of significant upcoming clinical trials See details

GSK PLC (ADR) - Competitors/Peers Analysis